Issue 14, 2001

αGal-conjugated anti-rhinovirus agents: chemo-enzymatic syntheses and testing of anti-Gal binding

Abstract

The syntheses of αGal-conjugated anti-rhinovirus agents 1, 2 and 3 and their abilities to inhibit αGal binding of human anti-Gal antibody are described. An efficient enzymatic glycosylation using a novel fusion protein serves to provide the key αGal intermediate 7, which is elaborated to αGal amines 9, 12 and 14 with various tethers. The conjugates are then formed by amide coupling of these amines to heterocyclic acid 18 in the presence of 1,1′-carbonyldiimidazole (CDI), followed by deprotection of the αGal part. Conjugate 3 having a triethylene glycol linker displays the highest binding affinity to human anti-Gal antibody as tested by ELISA.

Graphical abstract: αGal-conjugated anti-rhinovirus agents: chemo-enzymatic syntheses and testing of anti-Gal binding

Article information

Article type
Paper
Submitted
08 Jan 2001
Accepted
24 May 2001
First published
25 Jun 2001

J. Chem. Soc., Perkin Trans. 1, 2001, 1716-1722

αGal-conjugated anti-rhinovirus agents: chemo-enzymatic syntheses and testing of anti-Gal binding

Y. Chen, W. Zhang, X. Chen, J. Wang and P. G. Wang, J. Chem. Soc., Perkin Trans. 1, 2001, 1716 DOI: 10.1039/B100356I

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements